Smoking Cessation and Aids Market
Smoking Cessation and Aids Market Size:
Tobacco is one of the major causes of lung cancer and other cardiac and respiratory conditions. Awareness of these health hazards has affected people to take smoking cessation therapy. Consciousness in digital media, print media and other data sources has demonstrated some efficiency in curbing the crisis of nicotine addiction. According to the CDC, 14 out of 100 US adults 18 years of age or older 14.0% are presently smoking cigarettes in 2017. This suggests a strong use of de-sufficiency products. This also portrays peoples increasing consciousness and willingness to stop smoking. There are also NGOs and public institutions that teach and assist individuals to stop smoking dedicatedly in order to reduce the amount of smokers. For example, in 2017 an adult cessation campaign was initiated by the US Food and Drug Administration to encourage tobacco smokers to stop smoking. The introduction of new products and reimbursement for cessation of smoking are also factors which will help the market growth over the forecast period. However, one of the challenges faced by the drug therapy market for smoking cessation is the adverse effect of drugs.
Scope of the Report:
Tobacco use can lead to addiction on tobacco / nicotine and serious health problems. Quitting smoking significantly decreases the risk of developing smoking-related illnesses. Dependence on tobacco / nicotine is a disease that often needs repeated treatments, but there are useful treatments and quitting assets. Tobacco smoke includes a deadly combination of more than 7,000 chemicals, hundreds of which are dangerous, and about 70 can cause cancer. Smoking raises the risk of severe health issues, many diseases, and death. People who stop smoking significantly decrease their risk of disease and premature death.
Get a Free Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/smoking-cessation-and-aids-market
E-Cigarettes technology is expected to lead the market:
The market for smoking cessation aids is segmented into products, end users, and geography. Nicotine replacement treatment, alcohol, and electronic cigarettes further segment the product segment. E-cigarettes are an efficient option for decreasing tobacco-related health circumstances, while nicotine replacement therapies work best for cessation of smoking. E-cigarettes are a prospective threat to tobacco based cigarettes. At the same time, an opportunity for tobacco manufacturers to enter the smoking population into the new emerging segment catering. E-cigarette consumption is less damaging compared to standard tobacco, no smoke and no risk of passive smoking, permitted use even in non-smoking sites, varying nicotine levels, and availability in various flavors are some of the main driving factors for the e-cigarette market.
Asia Pacific is dominating the market growth during the forecast period:
Asia-Pacific is expected to be the fastest growing market region owing to increased awareness of smoking cessation and nicotine de-addiction products and a huge population base in the area. In a research released by JAMA Network March 2019 called Tobacco Smoking and Mortality in Asia, a pooled meta-analysis, an global research group led by those from Vanderbilt University, United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India. It was estimated that 8.3 million fatalities will be attributed to smoking by 2030, half of the world’s male smokers reside in China, India, and Indonesia and Asia is the world’s largest consumer and producer of tobacco.
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/smoking-cessation-and-aids-market
Market players in the market for smoking cessation aids involve various growth strategies such as collaborations, partnerships, agreements, mergers and acquisitions to enhance market presence. For example, in February 2019, Antidote Therapeutics announced a partnership with the National Cancer Institute to develop ATI-1013, a novel nicotine-binding antibody to reduce lung cancer in high risk smokers. In addition, introducing new products, working with government and NGOs to raise awareness of smoking cessation also boosts market growth. For example, in October 2018, Philip Morris initiated a campaign to encourage individuals to stop smoking, with advertisements in several UK journals. McNeil introduced QuickMist in Germany in January 2015, a fast-acting nicotine spray that replaces tobacco and promotes the victim.
About Us: –
Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe. We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available.
Name: Jennifer Daniel
Organization: Planet Market Reports